Cervical cancer detection kit HWTS-CC003A

oncologyHPVvaginal secretions

The kit can in vitro qualitative detection the 28 types of human papillomaviruses (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53 , 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nucleic acid, but can not be completely typed. It can only provide auxiliary means for the diagnosis and treatment of HPV infection. Epidemiology Cervical cancer is one of the most common malignant tumors in the female reproductive tract. The studies have shown that persistent infection and multiple infections of human papillomavirus is one of the important cause of cervical cancer. At present, there is still a lack of recognized effective treatment methods for HPV. Therefore, early detection and early prevention of cervical HPV is the key to blocking canceration. The establishment of a simple, specific and rapid pathogenic diagnostic method is of great significance in the clinical diagnosis of cervical cancer. Technical Parameters Storage - ≤-18℃ in dark Shelf-life - 12 months Specimen Type - Cervical exfoliated cells Ct - ≤28 CV - ≤5.0％ LoD - 25 Copies/reaction Specificity - No cross-reactivity with common reproductive tract pathogens (such as ureaplasma urealyticum, genital tract chlamydia trachomatis, candida albicans, neisseria gonorrhoeae, trichomonas vaginalis, mold, gardnerella and other HPV types not covered in the kit, etc). Applicable Instruments - It can match the mainstream fluorescent PCR instruments on the market. ABI 7500 Real-Time PCR Systems QuantStudio® 5 Real-Time PCR Systems SLAN-96P Real-Time PCR Systems LightCycler®480 Real-Time PCR system LineGene 9600 Plus Real-Time PCR Detection System MA-6000 Real-Time Quantitative Thermal Cycler